SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640455-21-000108
Filing Date
2021-06-22
Accepted
2021-06-22 16:34:40
Documents
2
Period of Report
2021-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162439406001292.html 4  
1 FORM 4 wf-form4_162439406001292.xml 4 4195
2 EXHIBIT 24 - KARSEN LIMITED POWER OF ATTORNEY ex-24.htm EX-24 4372
  Complete submission text file 0001640455-21-000108.txt   9929
Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
KARSEN PERRY A (Reporting) CIK: 0001260573 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37998 | Film No.: 211035759

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)